80
Views
11
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Does osteoprotegerin relate to micro- and macrovascular complications in long-term type 1 diabetes?

, , &
Pages 188-193 | Published online: 08 Mar 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jonas Vejvad Nørskov Laursen, Stine Skovbo Hoffmann, Anders Green, Mads Nybo, Anne Katrin Sjølie & Jakob Grauslund. (2013) Associations Between Diabetic Retinopathy and Plasma Levels of High-sensitive C-reactive Protein or Von Willebrand Factor in Long-term Type 1 Diabetic Patients. Current Eye Research 38:1, pages 174-179.
Read now

Articles from other publishers (10)

Silvia Garavelli, Sara Bruzzaniti, Elena Tagliabue, Dario Di Silvestre, Francesco Prattichizzo, Enza Mozzillo, Valentina Fattorusso, Lucia La Sala, Antonio Ceriello, Annibale A. Puca, Pierluigi Mauri, Rocky Strollo, Marco Marigliano, Claudio Maffeis, Alessandra Petrelli, Emanuele Bosi, Adriana Franzese, Mario Galgani, Giuseppe Matarese & Paola de Candia. (2020) Plasma circulating miR-23~27~24 clusters correlate with the immunometabolic derangement and predict C-peptide loss in children with type 1 diabetes. Diabetologia 63:12, pages 2699-2712.
Crossref
Kyriaki Karavanaki, Emmanouil Tsouvalas, Marina Vakaki, Alexandra Soldatou, Charalambos Tsentidis, George Kaparos, Areti Augoulea, Andreas Alexandrou & Ιrene Lambrinoudaki. (2018) Carotid intima media thickness and associations with serum osteoprotegerin and s-RANKL in children and adolescents with type 1 diabetes mellitus with increased risk for endothelial dysfunction. Journal of Pediatric Endocrinology and Metabolism 0:0.
Crossref
Dionisios Chrysis, Alexandra Efthymiadou, Alexandra Mermigka, Dimitra Kritikou & Bessie E Spiliotis. (2017) Osteoprotegerin, RANKL, ADMA, and Fetuin-A serum levels in children with type I diabetes mellitus. Pediatric Diabetes 18:4, pages 277-282.
Crossref
Ons Fekih, Hamdi Triki, Sonia Triki, Fadoua Neffati, Slaheddine Chouchane, Mohamed Neji Guediche & Mohamed Fadhel Najjar. (2017) Osteoprotegerin as a marker of cardiovascular risk in children and adolescents with type 1 diabetes. Pediatric Diabetes 18:3, pages 230-236.
Crossref
Emilie H. Zobel, Bernt J. von Scholten, Maria Lajer, Anders Jorsal, Lise Tarnow, Lars M. Rasmussen, Per Holstein, Hans-Henrik Parving, T.W. Hansen & P. Rossing. (2016) High osteoprotegerin is associated with development of foot ulcer in type 1 diabetes. Journal of Diabetes and its Complications 30:8, pages 1603-1608.
Crossref
C. Pérez de Ciriza, A. Lawrie & N. Varo. (2015) Osteoprotegerin in Cardiometabolic Disorders. International Journal of Endocrinology 2015, pages 1-15.
Crossref
A. Esteghamati, A. Arefzadeh, A. Zandieh, M. Salehi Sadaghiani, S. Noshad & M. Nakhjavani. (2014) Comparison of osteoprotegerin and vascular endothelial growth factor in normoalbuminuric Type 1 diabetic and control subjects. Journal of Endocrinological Investigation 36:7, pages 474-477.
Crossref
Sara Mankoč Ramuš, Tina Kumše, Mojca Globočnik Petrovič, Daniel Petrovič & Ines Cilenšek. (2013) SNP rs2073618 of the Osteoprotegerin Gene Is Associated with Diabetic Retinopathy in Slovenian Patients with Type 2 Diabetes. BioMed Research International 2013, pages 1-6.
Crossref
Areti Augoulea, Nikolaos Vrachnis, Irene Lambrinoudaki, Konstantinos Dafopoulos, Zoe Iliodromiti, Angelos Daniilidis, Michail Varras, Andreas Alexandrou, Efthymios Deligeoroglou & George Creatsas. (2013) Osteoprotegerin as a Marker of Atherosclerosis in Diabetic Patients. International Journal of Endocrinology 2013, pages 1-6.
Crossref
Tamás Rőszer. (2010) Inflammation as death or life signal in diabetic fracture healing. Inflammation Research 60:1, pages 3-10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.